CU6 0.11% $8.73 clarity pharmaceuticals ltd

CU6 - Media and Industry News, page-314

  1. 2,049 Posts.
    lightbulb Created with Sketch. 359
    AT stated clinicians had asked him to prioritise PC for Bombesin. I suspect there was an unmet need for non PSMA cancer.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.